Fundraising Fox
SÊMEIA
Paris, FR · Founded 2017 · 70 employees on LinkedIn · 6 known investors
Find your way into SÊMEIA
Sign up to see every warm intro you have to SÊMEIA
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SÊMEIA team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sêmeia builds MedicWise, a digital medical device for remote patient monitoring that automatically collects, structures, and analyzes health data for patients with chronic conditions. It serves physicians tracking chronic and long-term illness patients in France, with capabilities such as predicting kidney transplant rejection and graft survival.
Founders & leadership
SÊMEIA was founded in 2017 by Mathieu Godart.
Investors · 6
Acton Capitallisted by Acton CapitalMunich · $5.4M – $10.8M
How we know: Acton Capital's portfolio page · trysignalbase.com · Not right? Tell us
Also in the syndicate · 3
Banque des TerritoiresMutuelles ImpactOrange Ventures
In the news
Frequently asked questions
- What does SÊMEIA do?
- Sêmeia builds MedicWise, a digital medical device for remote patient monitoring that automatically collects, structures, and analyzes health data for patients with chronic conditions. It serves physicians tracking chronic and long-term illness patients in France, with capabilities such as predicting kidney transplant rejection and graft survival.
- Who founded SÊMEIA?
- SÊMEIA was founded by Mathieu Godart in 2017.
- Who are SÊMEIA's investors?
- SÊMEIA's investors include Acton Capital, XAnge, Citizen Capital.
- Where is SÊMEIA headquartered?
- SÊMEIA is headquartered in Paris, FR.